sarilumab - Clinical Trials Arena
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here

A closer look at Regeneron and its efforts to provide the world with a Covid-19 treatment

Regeneron is testing sarilumab – an existing rheumatoid arthritis drug – in Covid-19 patients (Credit: Regeneron/Sanofi)